Stock Updates

How has Abbott Laboratories:(NYSE:ABT) performed recently?

Abbott Laboratories (NYSE: ABT) is a large market cap stock with a market cap of 63020.3. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 32.8, a forward P/E of 17.41 and EPS of 1.3. At a stock price of 42.74 (1.52%) it has a dividend yield of 2.43%.

EPS growth for the last five years have been -10.30%, more recently this last year it has grown by 53.50%. The next year growth is going to be about 11.69% and more long-term 9.61% after five years. EPS growth quarter over quarter is -22.60%. Sales growth for the past five years have been -10.30% and sales growth quarter over quarter is 3.20%.

For performance, Abbott Laboratories the past week has seen a gain of 1.06%. For the last month performance for Abbott Laboratories is 1.38%. While the last quarter is 3.97% and half year, 1.54%. Finally for the year, performance is 9.78%.

The 52-week high for Abbott Laboratories, is at -6.66%, and for the 52-week low it comes to a value of 20.18%. The 20-day simple moving average is -0.92% and 5.06% for the 200-day simple moving average.

Volatility for the week is at 1.86%, and for the month it is 1.59%. Abbott Laboratories, has a target price of 7.43.

In terms of debt, long term debt/equity is 0.29, and for total debt/equity Abbott Laboratories has 0.41. The gross margin is 56.90%, while operating margin is 14.00%, the profit margin is 11.10%. The current ratio is 1.5 and the quick ratio is 1.2.

Insider ownership is at 0.30%, with instituitional ownership at 73.90%. Abbott Laboratories has a payout ratio of 66.50%. With the total shares outstanding coming to 1474.5. The shares float is 1465.05, with the float short at 4.62%, with short ratio coming to 7.22.

In terms of returns, the return on assets see Abbott Laboratories, get 5.60%, with its returns on investment at 7.70%. Return on equity is 10.90%. So will the investors see the target price of 7.43, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment